Plunkett Research Online: MorphoSys AG

MORPHOSYS AG (MPSYF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

MorphoSys has developed new technologies relating to the generation of recombinant antibodies, which set the standard for how antibodies will be made in the future. These technologies provide rapid and direct access to fully human antibodies for use as research tools, diagnostics and therapeutics......



MorphoSys AG
Ticker: MPSYF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 49 8989927-0
Fax: 49 8989927-222
Address: Semmelweisstrasse 7
Planegg, 82152 Germany

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
Gerald MollerChairman of the Board/Director
Frank MorichDeputy Chairman/Director
See More
MorphoSys has developed new technologies relating to the generation of recombinant antibodies, which set the standard for how antibodies will be made in the future. These technologies provide rapid and direct access to fully human antibodies for use as research tools, diagnostics and therapeutics......See More See More

Auditor: PricewaterhouseCoopers AG Wirtschaftsprufungsgesellschaft
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: